Allogene Therapeutics Announces Participation in Five Upcoming Virtual Investor Conferences

NEXT STORY
Global Digital Therapeutics Market By End Use, By Applications, By Regional Outlook, Industry Analysis Report and Forecast, 2021 – 2027
PREV STORY
TRACON Pharmaceuticals Announces Poster Presentations at the 2021 ASCO Virtual Annual Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Emergent BioSolutions’ COVID-19 Human Immune Globulin Product Candidate to be Evaluated in NIH-Sponsored Phase 3 Clinical Trial (INSIGHT-012) of Hyperimmune Intravenous Immunoglobulin for Outpatient Treatment of COVID-19

author_avatar
NASDAQ Market News

Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

BOSTON, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq:PRTK), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

Multiple Abstracts Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) to be Presented at the American Headache Society’s 61st Annual Scientific Meeting

author_avatar
NASDAQ Market News